Tenofovir disoproxil, usually shortened to TDF, is one of the most widely prescribed antiretroviral medicines in the world. In the UK it is the backbone of standard PrEP and a component of several HIV treatment combinations. It is prescription-only and should be taken as prescribed rather than adjusted independently.
What kind of drug is it?
A nucleotide reverse transcriptase inhibitor. It belongs to the oldest class of HIV medicines, developed around the idea of feeding the virus a defective building block. It is a prodrug, meaning it is inactive as swallowed and has to be converted inside the body before it does anything.
How does it work?
HIV carries its genetic information as RNA and must convert that into DNA before it can establish itself in a cell, using an enzyme called reverse transcriptase. Once converted to its active form, tenofovir diphosphate, the drug closely resembles one of the natural building blocks that enzyme uses.
What happens when the virus takes it up?
The enzyme incorporates it into the growing DNA chain, at which point the chain cannot be extended. The natural building block has a chemical attachment point for the next one; tenofovir does not. Replication stops at that point, which is why this mechanism is called chain termination.
Why does it need converting first?
Because the active form carries an electrical charge that prevents it crossing cell membranes. The disoproxil part of the name is a chemical modification that allows absorption from the gut, after which enzymes strip it away and the body adds the phosphate groups that make it active.
What is it used for?
Three things. As pre-exposure prophylaxis, combined with emtricitabine, to prevent HIV in people who are negative. As part of combination treatment for people living with HIV, always alongside other antiretrovirals. And as treatment for chronic hepatitis B, against which it is also effective.
Why is it used for PrEP specifically?
Because it reaches useful concentrations in the tissues where HIV would establish itself, particularly rectal tissue, and because it stays active inside cells long enough for once-daily dosing to work. Combined with emtricitabine it became the first and remains the standard oral PrEP.
Why is it never used alone for HIV?
Because HIV mutates rapidly, and a single drug allows resistant virus to emerge within weeks. Combination therapy attacks the virus at more than one point simultaneously, which is why modern treatment always involves at least two active drugs and why nobody is prescribed tenofovir on its own.
How does it work against hepatitis B?
Hepatitis B also uses a reverse transcriptase step in its life cycle, so the same mechanism applies. This matters practically: anyone starting tenofovir is tested for hepatitis B first, because stopping it abruptly in someone with chronic infection can cause a serious flare of liver inflammation.
Is it the same as tenofovir alafenamide?
No, though both deliver the same active drug. Alafenamide is a newer prodrug that converts more efficiently inside cells, so a much smaller dose achieves the same effect with less tenofovir circulating in the blood. That difference is what changes the side effect profile between them.
Where does it sit in current practice?
Still central. It has been available for over two decades, is available generically, and remains first-line for PrEP in UK guidance. For treatment it has been partly displaced by alafenamide in newer combinations, and both remain in widespread use.
Who typically takes it?
In the UK, most people on PrEP and a substantial proportion of people on HIV treatment. It is also given to people with chronic hepatitis B who do not have HIV. Across those three groups it is one of the most commonly dispensed medicines in sexual health.
Does it prevent anything else?
No. It covers HIV and hepatitis B and nothing else. Gonorrhoea, chlamydia, syphilis, herpes and mpox are entirely unaffected, which is why the three-monthly screening that comes with a PrEP prescription matters as much as the tablets do.
Where does it sit against the alternatives?
No antiretroviral is best in every situation. What matters is the fit between the drug and your kidney function, your other medicines, your hepatitis status, your resistance history and how you actually live. That is a conversation with a clinician rather than a ranking.